DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

Por Morgan, C, Jin, X, Yu, X, De Rosa, S, Kublin, J, Metch, B, Keefer, M, NIAID, H
Publicado em 2012

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Por Gray, GE, Metch, B, Churchyard, G, Mlisana, K, Nchabeleng, M, Allen, M, Moodie, Z, Kublin, J, Bekker, L-G
Publicado em 2013

P13-05. Factors associated with pregnancy during the HVTN 503/Phambili trial, a phase IIB HIV trial of the Merck Ad-5 multi-clade HIV vaccine

Por Latka, M, Grey, G, Fielding, K, Bekker, L, Mlisana, K, Nchabeleng, M, DeBruin, G, Allen, M, Kublin, J, Churchyard, G
Publicado em 2009

P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Por Allen, MA, Gray, G, Churchyard, G, Bekker, L, Nchabeleng, M, Mlisana, K, Metch, B, Moodie, Z, Roux, S, Mathebula, M, Bennie, T, Kublin, J
Publicado em 2009

Ocular disease in patients with tuberculosis and HIV presenting with fever in Africa

Por Beare, N A V, Kublin, J G, Lewis, D K, Schijffelen, M J, Peters, R P H, Joaki, G, Kumwenda, J, Zijlstra, E E
Publicado em 2002

P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial

Por de Bruyn, G, Mlisana, K, Metch, B, Churchyard, G, Nchabeleng, M, Bekker, L, Roux, S, Naicker, N, Latka, M, Corey, L, Kublin, J, Gray, G
Publicado em 2009

P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research

Por Mark, D, Middelkoop, K, Roux, S, Gray, G, Mlisana, K, Nchabaleng, M, Churchyard, G, De Bruyn, G, Latka, M, Magagula, D, Kublin, J, Allen, M, Bekker, L
Publicado em 2009

P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?

Por Gray, GE, Bekker, L, Churchyard, G, Nchabeleng, M, Mlisana, K, de Bruyn, G, Roux, S, Mathebula, M, Latka, M, Bennie, T, Metch, B, Moodie, Z, Allen, M, Eaton, N, Kublin, J
Publicado em 2009

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial

Por Hertz, T., Logan, M.G., Rolland, M., Magaret, C.A., Rademeyer, C., Fiore-Gartland, A., Edlefsen, P.T., DeCamp, A., Ahmed, H., Ngandu, N., Larsen, B.B., Frahm, N., Marais, J., Thebus, R., Geraghty, D., Hural, J., Corey, L., Kublin, J., Gray, G., McElrath, M.J., Mullins, J.I., Gilbert, P.B., Williamson, C.
Publicado no Vaccine (2016)